Colgate-Palmolive Company $CL Shares Sold by Grandfield & Dodd LLC

Grandfield & Dodd LLC decreased its holdings in shares of Colgate-Palmolive Company (NYSE:CL) by 3.9% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 20,135 shares of the company’s stock after selling 822 shares during the quarter. Grandfield & Dodd LLC’s holdings in Colgate-Palmolive were worth $1,830,000 as of its most recent SEC filing.

Other institutional investors have also recently added to or reduced their stakes in the company. Brighton Jones LLC lifted its holdings in shares of Colgate-Palmolive by 4.4% during the 4th quarter. Brighton Jones LLC now owns 10,578 shares of the company’s stock worth $962,000 after acquiring an additional 450 shares during the period. Stephens Inc. AR lifted its holdings in shares of Colgate-Palmolive by 6.1% during the 1st quarter. Stephens Inc. AR now owns 15,391 shares of the company’s stock valued at $1,442,000 after acquiring an additional 885 shares in the last quarter. Edgestream Partners L.P. acquired a new stake in Colgate-Palmolive in the 1st quarter valued at $1,854,000. Sigma Planning Corp raised its position in Colgate-Palmolive by 14.1% in the first quarter. Sigma Planning Corp now owns 6,795 shares of the company’s stock valued at $637,000 after purchasing an additional 839 shares during the period. Finally, Larson Financial Group LLC lifted its stake in shares of Colgate-Palmolive by 50.7% during the first quarter. Larson Financial Group LLC now owns 1,498 shares of the company’s stock worth $140,000 after purchasing an additional 504 shares in the last quarter. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Colgate-Palmolive Stock Up 0.2%

Shares of NYSE:CL opened at $78.71 on Friday. The firm has a market cap of $63.45 billion, a PE ratio of 22.11, a price-to-earnings-growth ratio of 4.44 and a beta of 0.35. The company has a fifty day simple moving average of $79.32 and a 200 day simple moving average of $85.35. The company has a current ratio of 0.89, a quick ratio of 0.57 and a debt-to-equity ratio of 6.79. Colgate-Palmolive Company has a 12-month low of $74.54 and a 12-month high of $100.18.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, October 31st. The company reported $0.91 EPS for the quarter, beating analysts’ consensus estimates of $0.89 by $0.02. The firm had revenue of $5.13 billion for the quarter, compared to the consensus estimate of $5.17 billion. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The firm’s revenue was up 1.9% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.91 EPS. On average, equities research analysts anticipate that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, November 14th. Stockholders of record on Friday, October 17th will be given a $0.52 dividend. The ex-dividend date is Friday, October 17th. This represents a $2.08 annualized dividend and a dividend yield of 2.6%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 58.26%.

Wall Street Analyst Weigh In

Several brokerages recently commented on CL. Raymond James Financial dropped their target price on Colgate-Palmolive from $105.00 to $95.00 and set an “outperform” rating on the stock in a report on Monday, October 20th. UBS Group lowered their price objective on shares of Colgate-Palmolive from $92.00 to $90.00 and set a “buy” rating for the company in a research report on Monday, November 3rd. Morgan Stanley dropped their price objective on shares of Colgate-Palmolive from $96.00 to $87.00 and set an “overweight” rating on the stock in a research note on Monday, November 3rd. Citigroup decreased their target price on shares of Colgate-Palmolive from $105.00 to $95.00 and set a “buy” rating for the company in a research note on Monday, November 3rd. Finally, The Goldman Sachs Group dropped their price target on shares of Colgate-Palmolive from $106.00 to $91.00 and set a “buy” rating on the stock in a research note on Thursday, October 2nd. Nine research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, Colgate-Palmolive currently has a consensus rating of “Moderate Buy” and a consensus price target of $89.87.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.